Search Results - "Adam, David N"

Management of Moderate‐to‐Severe Atopic Dermatitis With Systemic Medications: Review and Expert Commentary.

Authors: Adam, David N. Dhadwal, Gurbir Grewal, Parbeer et al.

Source: Dermatologic Therapy. 6/19/2026, Vol. 2026, p1-17. 17p.

Matching-Adjusted Indirect Comparison of Long-Term Efficacy and Safety Outcomes for Calcipotriol Plus Betamethasone Dipropionate Foam Versus Halobetasol Proprionate Plus Tazarotene Lotion in the Treatment of Plaque Psoriasis.

Authors: Adam, David N. Jablonski Bernasconi, Marie Y. Thoning, Henrik et al.

Source: Dermatology & Therapy. Nov2022, Vol. 12 Issue 11, p2589-2600. 12p.

Practical Considerations for the Recognition and Assessment of Chronic Hand Eczema.

Authors: Adam, David N. Devani, Alim R. Lovegrove, Fiona E. et al.

Source: Journal of Cutaneous Medicine & Surgery. 2026 Suppl 2, Vol. 30, p15-15. 1p.

Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc Analysis.

Authors: Silverberg, Jonathan I. Adam, David N. Zirwas, Matthew et al.

Source: American Journal of Clinical Dermatology. Jul2022, Vol. 23 Issue 4, p547-559. 13p.

Efficacy and safety of roflumilast cream for chronic plaque psoriasis with facial/neck and intertriginous area involvement: a post hoc analysis from a randomized controlled trial.

Authors: Draelos, Zoe D Adam, David N Hong, H Chih-ho et al.

Source: British Journal of Dermatology. Jun2023, Vol. 188 Issue 6, p810-812. 3p.

A Survey of Ontario Dermatologists' Practice Patterns in the Management of Vitiligo.

Authors: Adam, David N. Beecker, Jennifer Joseph, Marissa

Source: Journal of Cutaneous Medicine & Surgery. Nov2024, Vol. 28 Issue 6, p596-597. 2p.

Proactive Topical Maintenance Treatment of Psoriasis: Subanalysis of Canadian Patients in the Phase III PSO-LONG Trial.

Authors: Hong, H. Chih-ho Adam, David N. Rivers, Jason K. et al.

Source: Journal of Cutaneous Medicine & Surgery. Jan2023, Vol. 27 Issue 1, p63-64. 2p.

Bench to bedside: mechanistic principles of targeting the RAF kinase in melanoma.

Authors: Rajakulendran, Thanashan Adam, David N.

Source: International Journal of Dermatology. Dec2014, Vol. 53 Issue 12, p1428-1433. 6p.

Transdermal rivastigmine: management of cutaneous adverse events and review of the literature.

Authors: Greenspoon J Herrmann N Adam DN et al.

Source: CNS Drugs. 2011, Vol. 25 Issue 7, p575-583. 9p.

Transdermal Rivastigmine.

Authors: Greenspoon, Jill Herrmann, Nathan Adam, David N.

Source: CNS Drugs. 2011, Vol. 25 Issue 7, p575-583. 9p. 2 Color Photographs, 1 Diagram.

Subjects: Alzheimer's disease, Neurodegeneration, Cholinesterase inhibitors, Dementia, Transdermal medication, Skin inflammation, Edema, Erythema

Efficacy of a Day-Care Program in the Treatment of Psoriasis.

Authors: Zhang, Junling Adam, David N. Stebbing, Elaine et al.

Source: Journal of Cutaneous Medicine & Surgery. Sep/Oct2008, Vol. 12 Issue 5, p211-216. 6p.

Necrolytic Migratory Erythema: Case Report and Clinical Review.

Authors: Adam, David N. Cohen, Paul D. Sibbald, R. Gary et al.

Source: Journal of Cutaneous Medicine & Surgery. Jul/Aug2003, Vol. 7 Issue 4, p333-338. 6p.

Definition of Moderate to Severe Hidradenitis Suppurativa: A Position Paper by the Canadian Hidradenitis Suppurativa Foundation (CHSF).

Authors: Alavi, Afsaneh Adam, David N. Alhusayen, Ra'ed et al.

Source: Journal of Cutaneous Medicine & Surgery. Nov/Dec2016, Vol. 20 Issue 6, p613-615. 3p.

382 Lebrikizumab provides clinically meaningful improvements in atopic dermatitis in patients previously treated with dupilumab.

Authors: Gold, Linda Stein Gutermuth, Jan Adam, David N et al.

Source: British Journal of Dermatology. 2023 Supplement, Vol. 188, p1-3. 3p.

Practical Management of Patients with Atopic Dermatitis on Dupilumab.

Authors: Papp, Kim A. Hong, Chih-ho Lansang, M. Perla et al.

Source: Dermatology & Therapy. Oct2021, Vol. 11 Issue 5, p1805-1828. 24p.

Localized topical steroid use and central serous retinopathy.

Authors: Chan, Lauren Y. Adam, Robert S. Adam, David N.

Source: Journal of Dermatological Treatment. Oct2016, Vol. 27 Issue 5, p425-426. 2p.

Pyogenic Granuloma of the Foot with Satellitosis: A Role for Conservative Management.

Authors: Bacher, Janice Assaad, Dalal Adam, David N.

Source: Journal of Cutaneous Medicine & Surgery. Jan/Feb2011, Vol. 15 Issue 1, p58-60. 3p.

Plasmapheresis and Steroid Treatment of Levamisole-Induced Vasculopathy and Associated Skin Necrosis in Crack/Cocaine Users.

Authors: Pavenski, Katerina Vandenberghe, Hilde Jakubovic, Henry et al.

Source: Journal of Cutaneous Medicine & Surgery. Mar/Apr2013, Vol. 17 Issue 2, p123-128. 6p.

Optimizing the management of psoriasis in patients with skin of color: A Canadian Delphi consensus.

Authors: Yadav G Miller-Monthrope Y Rao J et al.

Source: JAAD international [JAAD Int] 2024 Nov 14; Vol. 19, pp. 12-20. Date of Electronic Publication: 2024 Nov 14 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774762 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-3287 (Electronic) Linking ISSN: 26663287 NLM ISO Abbreviation: JAAD Int Subsets: PubMed not MEDLINE

Long-term safety and effectiveness of roflumilast cream 0.3% in adults with chronic plaque psoriasis: A 52-week, phase 2, open-label trial.

Authors: Stein Gold L Adam DN Albrecht L et al.

Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Aug; Vol. 91 (2), pp. 273-280. Date of Electronic Publication: 2024 Mar 29.

Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study

Journal Info: Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787 (Electronic) Linking ISSN: 01909622 NLM ISO Abbreviation: J Am Acad Dermatol Subsets: MEDLINE